Cargando…

FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy

BACKGROUND: The aim was to investigate the correlation between (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) metabolic response to chemoradiotherapy and clinical outcomes in squamous cell carcinoma (SCC) of the anus. METHODS: A total of 48 patients with biopsy-proven anal SCC under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Day, F L, Link, E, Ngan, S, Leong, T, Moodie, K, Lynch, C, Michael, M, Winton, E de, Hogg, A, Hicks, R J, Heriot, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170972/ https://www.ncbi.nlm.nih.gov/pubmed/21792197 http://dx.doi.org/10.1038/bjc.2011.274

Ejemplares similares

The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer
por: Winton, E de, et al.
Publicado: (2009)

Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer
por: Michael, M, et al.
Publicado: (2014)

Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy
por: Charnley, N, et al.
Publicado: (2005)

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option
por: Meulendijks, D, et al.
Publicado: (2014)

Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients
por: Catalano, O A, et al.
Publicado: (2015)

A pilot study investigating the role of (18)F‐FDG‐PET in the early identification of chemoradiotherapy response in anal cancer
por: Smith, Drew, et al.
Publicado: (2022)

PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Travaini, Laura L, et al.
Publicado: (2016)

Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy
por: Jones, Michael, et al.
Publicado: (2015)

FDG PET/CT in Initial Staging of Adult Soft-Tissue Sarcoma
por: Roberge, David, et al.
Publicado: (2012)

Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma
por: Arrangoiz, Rodrigo, et al.
Publicado: (2012)

Early detection of recurrence by (18)FDG-PET in the follow-up of patients with colorectal cancer
por: Sobhani, I, et al.
Publicado: (2008)

Potential Pitfall in the Assessment of Lung Cancer with FDG-PET/CT: Talc Pleurodesis Causes Intrathoracic Nodal FDG Avidity
por: Wang, Yingbing, et al.
Publicado: (2013)

Impact of combined (18)F-FDG PET/CT in head and neck tumours
por: Syed, R, et al.
Publicado: (2005)

Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer
por: Le Thiec, Maelle, et al.
Publicado: (2020)

Time Sensitivity Factor of Single Pulmonary Nodule: A New Cancer Characteristic Metabolic Parameter by (18) F-FDG PET
por: Cheng, Ching-Yuan, et al.
Publicado: (2014)

Radiomic Profiling of Head and Neck Cancer: (18)F-FDG PET Texture Analysis as Predictor of Patient Survival
por: Feliciani, G., et al.
Publicado: (2018)

Investigation of Dose Minimisation Protocol for (18)F-FDG PET-CT in the Management of Lymphoma Postchemotherapy Followup
por: Sonoda, L. I., et al.
Publicado: (2012)

Whither Anal Cancer?
por: Heriot, Alexander G.
Publicado: (2020)

Prediction of Anal Cancer Recurrence After Chemoradiotherapy Using Quantitative Image Features Extracted From Serial (18)F-FDG PET/CT
por: Wang, Jiahui, et al.
Publicado: (2019)

The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients
por: Koleva-Kolarova, R G, et al.
Publicado: (2015)

Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer
por: Atsumi, Kazushige, et al.
Publicado: (2013)

Potential of (18)F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer
por: Choi, Noah C., et al.
Publicado: (2013)

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas
por: Benz, Matthias R., et al.
Publicado: (2010)

Prognostic Value of (18)F-FDG PET-CT in Nasopharyngeal Carcinoma: Is Dynamic Scanning Helpful?
por: Huang, Bingsheng, et al.
Publicado: (2015)

Anal Involvement in Pemphigus Vularis
por: Khezri, Somayeh, et al.
Publicado: (2013)

What Is the Clinical Significance of FDG Unexpected Uptake in the Prostate in Patients Undergoing PET/CT for Other Malignancies?
por: Bhosale, Priya, et al.
Publicado: (2013)

Automatic Segmentation of Lung Carcinoma Using 3D Texture Features in 18-FDG PET/CT
por: Markel, Daniel, et al.
Publicado: (2013)

The Incremental Prognostic Value of Baseline (18)F-FDG PET/CT Imaging in Angioimmunoblastic T-Cell Lymphoma
por: Wang, Hui, et al.
Publicado: (2020)

The use of (18)F-FDG PET to differentiate progressive disease from treatment induced necrosis in high grade glioma
por: Dankbaar, J. W., et al.
Publicado: (2015)

Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α
por: Kornmann, M, et al.
Publicado: (2010)

Correlation between Calcitonin Levels and [(18)F]FDG-PET/CT in the Detection of Recurrence in Patients with Sporadic and Hereditary Medullary Thyroid Cancer
por: Skoura, Evangelia, et al.
Publicado: (2012)

FDG-PET of Takayasu’s Arteritis
por: Shikino, Kiyoshi, et al.
Publicado: (2014)

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
por: De Bruyne, S, et al.
Publicado: (2012)

(18)F-FDG PET/CT for Diagnosis of Osteosclerotic and Osteolytic Vertebral Metastatic Lesions: Comparison with Bone Scintigraphy
por: Uchida, Kenzo, et al.
Publicado: (2013)

Post-operative Changes of Cerebral Glucose Metabolism in Patients with Lumbar Spinal Stenosis with Pre-operative Anxiety: Statistical Parametric Mapping Analysis of F-18 FDG Brain PET
por: Kim, Seong-Jang, et al.
Publicado: (2011)

FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma
por: Krengli, Marco, et al.
Publicado: (2010)

Concurrent FDG Avid Nasopharyngeal Lesion and Generalized Lymphadenopathy on PET-CT Imaging Is Indicative of Lymphoma in Patients with HIV Infection
por: Liu, Yiyan
Publicado: (2012)

Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn's Disease: A Pilot Study
por: Domachevsky, Liran, et al.
Publicado: (2017)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2008)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_pcjb4e4d96h9febq1nrqj54qog